Large Cap Biopharmaceuticals Performance 2023 YTD: Mixed Results But Lilly Is A Big Winner By: TalkMarkets August 21, 2023 at 13:31 PM EDT Biotech stocks are in a bear market since the IBB hit $177.37 in 2021 and is down 7.84% over five years. Read More >> Related Stocks: AbbVie Bristol-Myers Squibb Gilead Sciences HEALTHCARE Nasdaq Biotechnology Ishares ETF Pfizer Regeneron Pharmaceuticals UnitedHealth Group Vertex Pharmaceuticals
